{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T08:59:18Z","timestamp":1790326758650,"version":"4.1.0"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82160162"],"award-info":[{"award-number":["82160162"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81760150"],"award-info":[{"award-number":["81760150"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key Project of Jiangxi Provincial Natural Science Foundation","award":["20202ACBL206008"],"award-info":[{"award-number":["20202ACBL206008"]}]},{"name":"Second Affiliated Hospital of Nanchang University","award":["2022efyA04"],"award-info":[{"award-number":["2022efyA04"]}]},{"name":"Jiangxi Province Key Laboratory of Molecular Medicine","award":["2024SSY06231"],"award-info":[{"award-number":["2024SSY06231"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Results of previous studies have suggested that obstructive sleep apnea syndrome (OSAS), particularly when accompanied by obesity or diabetes, is linked to glucose metabolism disorders driven by abnormal glucagon-like peptide-1 (GLP-1) secretion. However, the efficacy of GLP-1 receptor agonists (RAs) in this population remains uncertain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>We conducted a meta-analysis to investigate the relationship between serum GLP-1 levels and OSAS, as well as the efficacy of GLP-1 RAs in treating OSAS<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data Sources<\/jats:title>\n                    <jats:p>The Cochrane, CINAHL, EMBASE, Google Scholar, PubMed, ScienceDirect, Web of Science, CNKI, and Wan Fang databases were searched from inception to October 1, 2024.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data Extraction<\/jats:title>\n                    <jats:p>We extracted data from the included studies on serum GLP-1 levels and the apnea\u2013hypopnea index (AHI), lowest SpO2 (LSpO2) levels, fasting blood glucose (FBG), glycated hemoglobin (HbA1c), body weight, body mass index (BMI), systolic blood pressure (SBP), and diastolic blood pressure (DBP).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data Analysis<\/jats:title>\n                    <jats:p>A total of 10 studies (1313 participants) were included in this analysis, comprising 4 case-control studies examining the relationship between serum GLP-1 levels and OSAS and 6 randomized controlled trials investigating the efficacy of GLP-1 RAs in patients with diabetes or obesity complicated by OSAS. Meta-analysis results indicated that compared to the non-OSAS or mild-OSAS individuals, fasting serum GLP-1 levels (mean difference [MD], \u22121.86 ug\/L; 95% CI, \u22123.58\u2009to\u2009\u22120.13; P\u2009=\u2009.04; I2\u2009=\u200972%), and 1-hour postprandial GLP-1 levels (MD, \u22127.76 \u00b5g\/L; 95% CI, \u22129.43\u2009to\u2009\u22126.08; P\u2009&amp;lt;\u2009.00001; I2\u2009=\u200949%) were significantly lower in patients with OSAS. Treatment with GLP-1 RA significantly improved the AHI (MD, \u221216.11 events\/h; 95% CI, \u221226.23\u2009to\u2009\u22125.99; P\u2009=\u2009.002; I2\u2009=\u200996%), as well as reducing blood pressure, BMI, and FBG (P\u2009&amp;lt;.05).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In patients with OSAS, serum GLP-1 levels are lower than those of healthy individuals. GLP-1 RAs may significantly reduce AHI in patients with obesity or diabetes. However, given the substantial heterogeneity among studies, the results should be interpreted with caution.<\/jats:p>\n                    <jats:p>Systematic Review Registration: \u2002PROSPERO registration No. CRD42024599675.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/nutrit\/nuaf115","type":"journal-article","created":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T07:15:06Z","timestamp":1748070906000},"page":"1099-1110","source":"Crossref","is-referenced-by-count":7,"title":["Efficacy of Glucagon-Like Peptide-1 Receptor Agonists in Obese or Diabetic Patients With Obstructive Sleep Apnea Syndrome: A Meta-Analysis"],"prefix":"10.1093","volume":"84","author":[{"given":"Shan","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, Second Affiliated Hospital of Nanchang University , Nanchang City, Jiangxi Province 330006,","place":["China"]},{"name":"Institute for the Study of Endocrinology and Metabolism in Jiangxi Province , Nanchang City, Jiangxi Province 330006,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin\u2019e","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Second Affiliated Hospital of Nanchang University , Nanchang City, Jiangxi Province 330006,","place":["China"]},{"name":"Institute for the Study of Endocrinology and Metabolism in Jiangxi Province , Nanchang City, Jiangxi Province 330006,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajun","family":"Qiu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Second Affiliated Hospital of Nanchang University , Nanchang City, Jiangxi Province 330006,","place":["China"]},{"name":"Branch of National Clinical Research Center for Metabolic Diseases, Second Affiliated Hospital of Nanchang University , Nanchang City, Jiangxi Province 330006,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuying","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Second Affiliated Hospital of Nanchang University , Nanchang City, Jiangxi Province 330006,","place":["China"]},{"name":"Jiangxi Key Laboratory of Molecular Medicine, The Second Affiliated Hospital of Nanchang University , Nanchang City, Jiangxi Province 330006,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqi","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Second Affiliated Hospital of Nanchang University , Nanchang City, Jiangxi Province 330006,","place":["China"]},{"name":"Jiangxi Key Laboratory of Molecular Medicine, The Second Affiliated Hospital of Nanchang University , Nanchang City, Jiangxi Province 330006,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0138-6845","authenticated-orcid":false,"given":"Jianping","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Second Affiliated Hospital of Nanchang University , Nanchang City, Jiangxi Province 330006,","place":["China"]},{"name":"Jiangxi Key Laboratory of Molecular Medicine, The Second Affiliated Hospital of Nanchang University , Nanchang City, Jiangxi Province 330006,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,7,23]]},"reference":[{"key":"2026051203522968700_nuaf115-B1","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1183\/16000617.0030-2019","article-title":"Sex differences in obstructive sleep apnoea","volume":"28","author":"Bonsignore","year":"2019","journal-title":"Eur Respir Rev"},{"key":"2026051203522968700_nuaf115-B2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00281-009-0148-5","article-title":"Obstructive sleep apnea, immuno-inflammation, and atherosclerosis","volume":"31","author":"Arnaud","year":"2009","journal-title":"Semin Immunopathol"},{"key":"2026051203522968700_nuaf115-B3","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1001\/jama.2020.3514","article-title":"Diagnosis and management of obstructive sleep apnea: a review","volume":"323","author":"Gottlieb","year":"2020","journal-title":"JAMA"},{"key":"2026051203522968700_nuaf115-B4","doi-asserted-by":"crossref","first-page":"e076410","DOI":"10.1136\/bmj-2023-076410","article-title":"Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis","volume":"384","author":"Yao","year":"2024","journal-title":"BMJ"},{"key":"2026051203522968700_nuaf115-B5","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/dom.15383","article-title":"Safety, pharmacokinetics and pharmacodynamics of HRS-7535, a novel oral small molecule glucagon-like peptide-1 receptor agonist, in healthy participants: a phase 1, randomized, double-blind, placebo-controlled, single- and multiple-ascending dose, and food effect trial","volume":"26","author":"Wu","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"2026051203522968700_nuaf115-B6","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1136\/thx.2006.062513","article-title":"Diabetes and sleep apnoea: a hidden epidemic?","volume":"61","author":"Wilding","year":"2006","journal-title":"Thorax"},{"key":"2026051203522968700_nuaf115-B7","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.chest.2017.05.009","article-title":"Obstructive sleep apnea and diabetes: a state of the art review","volume":"152","author":"Reutrakul","year":"2017","journal-title":"Chest"},{"key":"2026051203522968700_nuaf115-B8","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/S0140-6736(99)01376-8","article-title":"Impact of sleep debt on metabolic and endocrine function","volume":"354","author":"Spiegel","year":"1999","journal-title":"Lancet"},{"key":"2026051203522968700_nuaf115-B9","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1113\/jphysiol.2007.143586","article-title":"Intermittent hypoxia reverses the diurnal glucose rhythm and causes pancreatic beta-cell replication in mice","volume":"586","author":"Yokoe","year":"2008","journal-title":"J Physiol"},{"key":"2026051203522968700_nuaf115-B10","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2026051203522968700_nuaf115-B11","author":"Wells","year":"2014"},{"key":"2026051203522968700_nuaf115-B12","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"2026051203522968700_nuaf115-B13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"2026051203522968700_nuaf115-B14","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3760\/cma.j.issn.1674-5809.2015.05.003","article-title":"Changes of glucagon-like peptide-1 (GLP-1) and effects of GLP-1 analogues in type 2 diabetic patients with obstructive sleep apnea-hypopnea syndrome","volume":"7","author":"Zhang","year":"2015","journal-title":"Chin J Diabetes Mellitus"},{"key":"2026051203522968700_nuaf115-B15","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3760\/cma.j.issn.1673-436X.2012.013.006","article-title":"Study on the glucagon-like peptide-1 level in patients with obstructive sleep apnea-hypopnea syndrome","volume":"32","author":"Yang","year":"2012","journal-title":"Int J Respir"},{"key":"2026051203522968700_nuaf115-B16","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s12020-020-02369-3","article-title":"Sleep apnea in men is associated with altered lipid metabolism, glucose tolerance, insulin sensitivity, and body fat percentage","volume":"70","author":"Kamble","year":"2020","journal-title":"Endocrine"},{"key":"2026051203522968700_nuaf115-B17","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1513\/AnnalsATS.201510-697OC","article-title":"Plasma incretin levels and dipeptidyl peptidase-4 activity in patients with obstructive sleep apnea","volume":"13","author":"Matsumoto","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"2026051203522968700_nuaf115-B18","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/ijo.2016.52","article-title":"Effect of liraglutide 3.0\u2009mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial","volume":"40","author":"Blackman","year":"2016","journal-title":"Int J Obes (Lond)"},{"key":"2026051203522968700_nuaf115-B19","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.3969\/j.issn.1005-9202.2015.06.050","article-title":"Effect of liraglutide in the treatment of obstructive sleep apnea syndrome and obese type 2 diabetes mellitus","volume":"6","author":"Zhu","year":"2015","journal-title":"Chin J Gerontol"},{"key":"2026051203522968700_nuaf115-B20","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1007\/s11325-022-02768-y","article-title":"Efficacy and safety of liraglutide in patients with type 2 diabetes mellitus and severe obstructive sleep apnea","volume":"27","author":"Jiang","year":"2023","journal-title":"Sleep Breath"},{"key":"2026051203522968700_nuaf115-B21","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1056\/NEJMoa2404881","article-title":"Tirzepatide for the treatment of obstructive sleep apnea and obesity","volume":"391","author":"Malhotra","year":"2024","journal-title":"N Engl J Med"},{"key":"2026051203522968700_nuaf115-B22","doi-asserted-by":"publisher","first-page":"77","DOI":"10.7619\/jcmp.202010019","article-title":"Effect of exenatide on hypoxia status of patients with type 2 diabetes mellitus complicated with obstructive sleep apnea hypopnea syndrome","volume":"24","author":"Chen","year":"2020","journal-title":"J Clin Med Pract"},{"key":"2026051203522968700_nuaf115-B23","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1001\/jamaoto.2022.4615","article-title":"What is snoring?","volume":"149","author":"Huyett","year":"2023","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"2026051203522968700_nuaf115-B24","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1210\/endo.140.4.6643","article-title":"Role of the vagus nerve in mediating proximal nutrient-induced glucagon-like peptide-1 secretion","volume":"140","author":"Rocca","year":"1999","journal-title":"Endocrinology"},{"key":"2026051203522968700_nuaf115-B25","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/bph.15603","article-title":"Reappraising the role of the vagus nerve in GLP-1-mediated regulation of eating","volume":"179","author":"Brierley","year":"2022","journal-title":"Br J Pharmacol"},{"key":"2026051203522968700_nuaf115-B26","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1164\/ajrccm.165.5.2104087","article-title":"Sleep-disordered breathing and insulin resistance in middle-aged and overweight men","volume":"165","author":"Punjabi","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"2026051203522968700_nuaf115-B27","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cmet.2018.03.001","article-title":"Mechanisms of action and therapeutic application of glucagon-like peptide-1","volume":"27","author":"Drucker","year":"2018","journal-title":"Cell Metab"},{"key":"2026051203522968700_nuaf115-B28","doi-asserted-by":"crossref","first-page":"101641","DOI":"10.1016\/j.molmet.2022.101641","article-title":"Glucagon-like peptide-1 receptor Tie2+ cells are essential for the cardioprotective actions of liraglutide in mice with experimental myocardial infarction","volume":"66","author":"McLean","year":"2022","journal-title":"Mol Metab"},{"key":"2026051203522968700_nuaf115-B29","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1161\/atv.0000615456.97862.30","article-title":"Endothelial GLP-1 (glucagon-like peptide-1) receptor mediates cardiovascular protection by liraglutide in mice with experimental arterial hypertension","volume":"40","author":"Helmst\u00e4dter","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Nutrition Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/nutritionreviews\/article-pdf\/84\/6\/1099\/63834714\/nuaf115.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/nutritionreviews\/article-pdf\/84\/6\/1099\/63834714\/nuaf115.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T07:52:49Z","timestamp":1778572369000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/nutritionreviews\/article\/84\/6\/1099\/8211140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,23]]},"references-count":29,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,7,23]]},"published-print":{"date-parts":[[2026,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/nutrit\/nuaf115","relation":{},"ISSN":["0029-6643","1753-4887"],"issn-type":[{"value":"0029-6643","type":"print"},{"value":"1753-4887","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6]]},"published":{"date-parts":[[2025,7,23]]}}}